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Ab stra ct
La bo ra to ry diag nos ti cs is a me di cal dis cip li ne playi ng an im por ta nt pa rt in pa tie nt ma na ge me nt. In labo ra to ry medi ci ne mea nin gful, ac cu ra te and 
pre ci se rou ti ne mea su re men ts are es sen tial for diag no sis, ri sk as ses sme nt, treat me nt and fol low-up of pa tien ts. The con tri bu tion of the diag nos tic 
la bo ra to ry in the ove ra ll diag nos tic pro ce ss is app. 40–60%, de pen di ng on the ki nd of di sea se sta tus in ves ti ga ted. The diag nos tic la bo ra to ry uses 
nowa days mo re than 1.000 di2 e re nt tes ts mos tly pro vi ded by the in vit ro diag nos tic in dus try.
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The la bo ra to rian – a par tner of cli ni cal 
me di ci ne
The con tri bu tion of the diag nos tic la bo ra to ry in 
the ove ra ll diag nos tic pro cess is app. 40–60%, de-
pen di ng on the ki nd of di sea se sta tus in ves ti ga ted 
(1). The spe cia li st wor ki ng in the diag nos tic la bo ra-
to ry has to be ac ti ve ly in teg ra ted in the re la tion-
ship be tween pa tie nt and the doc to rs li ke the ra-
dio lo gi st who does not on ly pro du ce x-ray, CT- and 
MR-pic tu res, but al so gi ves his diag nos tic com-
men ts. The sa me has to be true for the la bo ra to-
rian usi ng pat hop hysio lo gi cal and cli ni cal know-
led ge as ba sis of his in ter pre ta tion of la bo ra to ry 
re sul ts. Sin ce the num ber of te st re sul ts in a patie-
nt re po rt is con ti nuous ly in crea si ng, the qua li ty of 
the re sul ts has to be mo ni to red by a qua li ty system 
dea li ng wi th all ste ps of the diag nos tic pro ce ss.
The diag nos tic pro ce ss
To ac hie ve the se goa ls, as we ll as to im pro ve the 
ove ra ll qua li ty, diag no stic la bo ra to ries are now im-
ple men ti ng eJ   cie nt qua li ty ma na ge me nt syste ms. 
Ma ny gui de li nes for qua li ty ma na ge me nt ha ve 
been pub lis hed so far (2–6). It is ge ne ral ly as su med 
that the pre-a na lyti cal, the ana lyti cal and the po st-
a na lyti cal ste ps in the ove ra ll diag nos tic pro ce ss wi ll 
be im pro ved and mo re eco no mi cal ly trig ge red wi-
th this ap proa ch. In mo st ap plied syste ms, howe ver, 
the me di cal, pa tie nt-re la ted pa rt whi ch dea ls wi th 
in ter pre ta tion of com plex con di tio ns is lac ki ng.
Ba si cal ly, the ove ra ll qua li ty of the diag nos tic pro-
ce ss de pen ds on the fol lowi ng ste ps:
1. Pre-a na lyti cs
• ratio na le, di sea se orien ted te st se lec tion, 
diag nos tic al go rit hms;
• infor ma tion about pa tie nt’s di sea se sta tus 
and me di ca tion;
• pre pa ra tion of the pa tie nt;
• sam pli ng of spe ci me ns;
• pre-a nalyti cal han dli ng of spe ci me ns (sto ri ng, 
tran spo rt con di tio ns);
• clear iden ti U  ca tion of pa tie nt sam ples.
2. Ana lyti cs
• use of ac cu ra te, pre ci se and tra ceab le ana-
lyti cal met ho ds;
• use of spe ci U c met ho ds;
• knowled ge of ana lyti cal in ter fe ren ces and li-
mi ta tio ns;
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• maintenan ce of ana lyti cal syste ms;
• sho rt tu rn arou nd ti me;
• inter nal qua li ty as su ran ce for ea ch te st;
• regu lar par ti ci pa tion in exter nal pro U  cien cy 
tes ti ng syste ms.
3. Po st-a na lyti cs
• struc tu red pa tie nt re por ts:
 – iden ti U  ca tion of pa tie nt (sex, age), da te of 
in ves tiga tion, cli ni cal diag no sis;
 – test re sul ts, re fe ren ce ran ges, bio lo gi cal 
va ria tion of an in di vi dual;
 – cli ni cal de ci sion le ve ls;
 – writ ten diag nos tic com men ts as a sum ma-
ry of com plex te st re sul ts;
• consul ta tion wi th cli ni cia ns on in di vi dual pa-
tie nt re sul ts in cases of com plex con di tio ns;
• fol low-up of la bo ra to ry re por ts on treat me nt 
of the pa tien ts.
The knowled ge of the cli ni cal sta tus of a pa tie nt is 
per ti ne nt for the cor re ct se lec tion of a la bo ra to ry 
te st. The sa me is true about the me di ca tion of the 
pa tie nt, since this mig ht ha ve an im pa ct on the 
ana lyti cal per for man ce of the te st. A wro ng or a 
not per for med te st mig ht re su lt in a wro ng cli ni cal 
diag no sis and is cos tly.
Pre-ana lyti cs
In se ve ral areas of la bo ra to ry me di ci ne, diag nos tic 
al go rit hms are cur ren tly used, as out li ned in se ve ral 
diag nos tic gui de li nes. This is eco no mi cal ly va lid and 
dec rea ses the per for man ce of use le ss tes ts. Exam-
ples of se ve ral diag nos tic gui de li nes in en doc ri no lo-
gy, dia be tes ca re, myo car dial in far ction and in fec-
tious di sea ses are referen ced (7–11). The ap pli ca tion 
of al go rit hms gi ves res pon si bi li ty to the la bo ra to ry 
and spee ds up the ana lyti cal pro ce ss, sin ce a sin gle 
sam ple is used for the step by step mea su re men ts. 
E.g., one ED TA-blood can be used for ce ll coun ti ng, 
fol lowed by mic rosco pic ce ll diY e ren tia tion and in 
ca se of the pre sen ce of pat ho lo gi cal cel ls by im mu-
nop he no typi ng usi ng Z ow-cyto met ry.
Ana lyti cs
The ove ra ll qua li ty of a diag nos tic la bo ra to ry de pen-
ds on the col la bo ra tion and the mu tual un der stan di-
ng be tween the par ties in vol ved, that are the la bo ra-
to ry pro fes sio nal and the cli ni cian. When in tro du ci ng 
a new te st or chan gi ng a system, it is a ki nd of qua li ty 
ser vi ce for the cli ni cia ns to in fo rm them about the 
fol lowi ng cha rac te ris ti cs of the new te st as we ll as 
to gi ve a ra tio na le expla na tion for the in tro duc tion:
• diag nos tic use ful ne ss of the te st for a cer tain di-
sea se;
 – rep la ce me nt of an out da ted te st or pro ce du re;
 – bene U  ts of the new te st (diag nos tic, eco no mic;)
 – impa ct on the ove ra ll or ga ni sa tion (cli ni cia ns, 
la bo ra to ry);
• diag nos tic spe ci U  ci ty and sen si ti vi ty of the te st;
• analyti cal per for man ce of the te st (ac cu ra cy, 
pre ci sion, in ter fe ren ces);
• age and sex re la ted re fe ren ce ran ges;
• clini cal de ci sion le ve ls ba sed on diag nos ti c-cli ni-
cal stu dies re le va nt for va rious me di cal dis cip li nes.
In spi te of the Eu ro pean Union (EU) In Vit ro Diag-
nos tic (IVD) Di rec ti ve 98/79 EC (12) and the in tro-
duc tion of tra cea bi li ty in la bo ra to ry me di ci ne (13), 
the sa me te st by diY e re nt IVD pro vi de rs mig ht gi ve 
diY e re nt re sul ts whi ch is cer tain ly confu si ng and 
mis lea di ng for cli ni cia ns. The re fo re, la bo ra to ry pro-
fes sio na ls and the IVD in dus try in col la bo ra tion wi th 
pro fes sio nal or ga ni sa tio ns li ke the In ter na tio nal Fe-
de ra tion of Cli ni cal Che mis try (IFCC) stri ve to ac hie-
ve ma jor har mo ni sa tion of la bo ratory te st re sul ts 
(in di vi dual re sul ts, re fe ren ce- and de ci sion le ve ls) by 
stan dar di sa tion. Stan dar di sa tion of all the se im por-
ta nt as pec ts wi ll im pro ve the ove ra ll diag nos tic 
qua li ty, wi ll ha ve an enor mous eco no mic im pa ct, 
and wi ll con tri bu te to uni fo rm test re sul ts over ti me 
and spa ce (14). As lo ng as this is not ac hie ved, the la-
bo ra to ry spe cia li st has to explain the se diY e ren ces 
to the pa tien ts and the cli ni cia ns, es pe cial ly when 
con fron ted wi th a re po rt from anot her la bo ra to ry.
Po st ana lyti cs
The in te rpreta tion of te st re sul ts is a key-e le me nt 
in la bo ra to ry diag nos ti cs. The la bo ra to ry pro fes-
sio nal has to in fo rm the cli ni cian im me dia te ly and 
per so nal ly about cri ti cal, li fe threa te ni ng re sul ts. A 
cor re ct in ter pre ta tion de pen ds on the in for ma tion 
about patient’s con di tio ns. In in sti tu tio ns wi th elec-
tro nic pa tie nt re cor ds this tool has to be used by the 
Biochemia Medica 2010;20(2):144–6
146
la bo ra to ry to im pro ve the qua li ty of its re por ti ng 
and ma ke it mo re spe ci U c for the in di vi dual pa tie nt.
Fu tu re: integ ra tion of the diag nos tic 
la bo ra to ry in cli ni cal me di ci ne
All ki nd of in di vi dual heal th da ta are sto red elec tro-
ni cal ly wit hin a good fun ctio ni ng heal th system. 
This shou ld be true not on ly for the la bo ra to ry da-
ta, but al so for cli ni cal in for ma tio ns li ke his to ry of 
di sea ses, treat me nt, me di ca tion, spe ci U c al ler gies, 
and ge ne tic dysfun ctio ns. All par ties in vol ved in 
the treat me nt of a pa tie nt shou ld use this fol lowi ng 
stri ct da ta pri va cy ru les to ob tain the hig he st the ra-
peu tic and diag nos tic qua li ty for the pa tie nt.
Pro fes sio na ls in la bo ra to ry medici ne ha ve been lo ng 
fo cu sed on the ana lyti cal pa rt of the to tal tes ti ng 
pro ce ss. It is ti me to go “out of the la bo ra to ry” and 
ma ke clo ser re la tion ship wi th cli ni cal sta Y . The re fo re, 
the re-in teg ra tion of the diag nos tic la bo ra to ry in to 
cli ni cal me di ci ne will in es sen ce be the main fu tu re 
goal of our dis cip li ne. The in teg ra tion of la bo ra to ry 
diag nos ti cs and the mo de rn tec hniques of mo le cu-
lar bio lo gy wi ll re su lt in in di vi dual treat men ts ba sed 
on spe ci U c diag nos tic te st. E.g., phar ma co ge ne ti cs 
tes ti ng wi ll enab le the cli ni cian to se le ct the mo st ac-
cu ra te drug in an op ti mal do sa ge for an in di vi dual 
pa tie nt, thus pre ven ti ng toxi ci ty and si de eY ec ts 
(15,16). Wi th the se new pos si bi li ties, the diag nos tic 
la bo ra to ry wi ll add to cli ni cal me di ci ne a new qua li ty.
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Kva li te ta i di jag nos tičke per spek ti ve u la bo ra to rij skoj di jag nos ti ci
Sažetak
La bo ra to rij ska di jag nos ti ka je me di cin ska dis cip li na ko ja ima važnu ulo gu u ob ra di bo les ni ka. U la bo ra to rij skoj su me di ci ni svr ho vi ta, točna i pre-
ciz na ru tin ska mje re nja od ključne važnosti za pos tav lja nje di jag no ze, proc je nu ri zi ka, li ječenje i praćenje bo les ni ka. Dop ri nos di jag nos tičkog la-
bo ra to ri ja cje lo kup nom di jag nos tičkom pro ce su kreće se oko 40–60%, ovis no o vr sti sta tu sa bo les ti ko ja se is tražuje. Da nas di jag nos tički labora-
to ri ji prim je nju ju više od 1.000 raz ličitih tes to va ko je nu di in vit ro di jag nos tička in dus tri ja.
Ključne ri ječi: la bo ra to rij ska me di ci na; di jag nos tički pro ces; pri jea na li tička fa za; pos li jea na li tička faza
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